Successful salvage treatment of recurrent endometrial cancer with bulky central tumor and extensive lymph node metastasis. A case report

被引:0
作者
Wu, YC
Huang, SL
Chuang, CK
Jung, SM
Lai, CH
机构
[1] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Taoyuan 333, Taiwan
[2] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Urol, Taoyuan 333, Taiwan
[3] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Pathol, Taoyuan 333, Taiwan
[4] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
关键词
endometrial cancer; lymph node metastasis; recurrence; chemoradiation; exenteration;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recurrent endometrial cancer with both local and distant metastasis is very difficult to treat. A 55-year-old endometrial adenocarcinoma patient with bulky central recurrences and pelvic and inguinal lymph node metastases underwent laparotomy and paraaortic, pelvic and inguinal lymphadenectomy followed by concurrent chemoradiation (with cisplatin) to the paraaortic and inguinal lymph nodes as well as the whole pelvis. Neck and mediastinal lymph node metastasis emerged during treatment. Neck-node radiation and epirubicin was added followed by paclitaxel and carboplatin. Complete remission was achieved. Ten months later, isolated central re-recurrence happened and total pelvic exenteration was performed. The patient has survived without further recurrence for more than five years after the exenteration. Therefore, a multimodality approach with a combination of radical resection (even pelvic exenteration), radiotherapy and chemotherapy could be offered to well-selected patients with recurrent endometrial cancer despite out-of-field progression during therapy and in-field local failure to initial salvage treatment.
引用
收藏
页码:739 / 741
页数:3
相关论文
共 12 条
[1]   RECURRENT ADENOCARCINOMA OF THE ENDOMETRIUM - A CLINICAL AND HISTOPATHOLOGICAL STUDY OF 379 PATIENTS [J].
AALDERS, JG ;
ABELER, V ;
KOLSTAD, P .
GYNECOLOGIC ONCOLOGY, 1984, 17 (01) :85-103
[2]   A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: A Gynecologic Oncology Group study [J].
Ball, HG ;
Blessing, JA ;
Lentz, SS ;
Mutch, DG .
GYNECOLOGIC ONCOLOGY, 1996, 62 (02) :278-281
[3]   Pelvic exenteration for recurrent endometrial cancer [J].
Barakat, RR ;
Goldman, NA ;
Patel, DA ;
Venkatraman, ES ;
Curtin, JP .
GYNECOLOGIC ONCOLOGY, 1999, 75 (01) :99-102
[4]   Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: A phase II study [J].
Hoskins, PJ ;
Swenerton, KD ;
Pike, JA ;
Wong, F ;
Lim, P ;
Acquino-Parsons, C ;
Lee, N .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (20) :4048-4053
[5]   Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer [J].
Jeyarajah, AR ;
Gallagher, CJ ;
Blake, PR ;
Oram, DH ;
Dowsett, M ;
Fisher, C ;
Oliver, RTD .
GYNECOLOGIC ONCOLOGY, 1996, 63 (01) :47-52
[6]   SYSTEMIC TREATMENT OF ADVANCED AND RECURRENT ENDOMETRIAL CARCINOMA - CURRENT STATUS AND FUTURE-DIRECTIONS [J].
MOORE, TD ;
PHILLIPS, PH ;
NERENSTONE, SR ;
CHESON, BD .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (06) :1071-1088
[7]   Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration [J].
Morris, M ;
Alvarez, RD ;
Kinney, WK ;
Wilson, TO .
GYNECOLOGIC ONCOLOGY, 1996, 60 (02) :288-291
[8]   Maximal cytoreductive surgery as a reasonable therapeutic alternative for recurrent endometrial carcinoma [J].
Scarabelli, C ;
Campagnutta, E ;
Giorda, G ;
DePiero, G ;
Sopracordevole, F ;
Quaranta, M ;
DeMarco, L .
GYNECOLOGIC ONCOLOGY, 1998, 70 (01) :90-93
[9]  
SEARS JD, 1994, CANCER, V74, P1303, DOI 10.1002/1097-0142(19940815)74:4<1303::AID-CNCR2820740420>3.0.CO
[10]  
2-G